The Evolving Treatment Landscape in Relapsed/Refractory Follicular Lymphoma

On September 8, 2022, OncLive® brought together physicians who treat FL to participate in a virtual workshop and discuss the treatment landscape and management of patients with relapsed/refractory (R/R) FL. The discussion was led by Krish Patel, MD; perspectives and insights on current treatment options, trial data, and other novel therapies were exchanged.

Madan L. Arora, MD, discusses the evolution of treatment in follicular lymphoma.

Solly Chedid, MD, discusses the elements of effective therapy in follicular lymphoma.

Krish Patel, MD, discusses the factors to consider when treating patients with relapsed and/or refractory follicular lymphoma.